Vertebral Fracture Assessment: The 2007 ISCD Official Positions

Journal of Clinical Densitometry

Volumn 11, Issue 1, 2008, Pages 92-108

  Schousboe, John T ^a,b   Vokes, Tamara ^c   Broy, Susan B ^d   Ferrar, Lynne ^e   McKiernan, Fergus ^f   Roux, Christian ^g   Binkley, Neil ^h  

^a PARK NICOLLET INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d ILLINOIS BONE AND JOINT INSTITUTE   (United States)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f MARSHFIELD CLINIC   (United States)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Dual energy X ray absorptiometry; fracture; guideline; imaging; position; vertebral fracture assessment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; PARATHYROID HORMONE[1-34]; RALOXIFENE;

ARTICLE; BONE DENSITY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG WITHDRAWAL; HAIR LOSS; HUMAN; MEDICAL SOCIETY; METHODOLOGY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPINE; VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; BONE DENSITY; CHILD; FEMALE; HUMANS; MALE; OSTEOPOROSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; SPINAL FRACTURES;

EID: 42649127068     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2007.12.008     Document Type: Article

References (229)

1. Melton III L.J., Kan S.H., Frye M.A., et al. Epidemiology of vertebral fractures in women. Am J Epidemiol 129 5 (1989) 1000-1011
2. Melton III L.J., Lane A.W., Cooper C., et al. Prevalence and incidence of vertebral deformities. Osteoporos Int 3 3 (1993) 113-119
3. Bouxsein M.L., Melton III L.J., Riggs B.L., et al. Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. J Bone Miner Res 21 9 (2006) 1475-1482
4. Jackson S.A., Tenenhouse A., and Robertson L. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11 8 (2000) 680-687
5. O'Neill T.W., Felsenberg D., Varlow J., et al. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11 7 (1996) 1010-1018
6. Spector T.D., McCloskey E.V., Doyle D.V., et al. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res 8 7 (1993) 817-822
7. Ismail A.A., Cooper C., Felsenberg D., et al. Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int 9 3 (1999) 206-213
8. Jones G., White C., Nguyen T., et al. Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women. Osteoporos Int 6 3 (1996) 233-239
9. Ling X., Cummings S.R., Mingwei Q., et al. Vertebral fractures in Beijing, China: the Beijing Osteoporosis Project. J Bone Miner Res 15 10 (2000) 2019-2025
10. Lau E.M., Chan Y.H., Chan M., et al. Vertebral deformity in Chinese men: prevalence, risk factors, bone mineral density, and body composition measurements. Calcif Tissue Int 66 1 (2000) 47-52
11. Tsai K., Twu S., Chieng P., et al. Prevalence of vertebral fractures in Chinese men and women in urban Taiwanese communities. Calcif Tissue Int 59 4 (1996) 249-253
12. Jinbayashi H., Aoyagi K., Ross P.D., et al. Prevalence of vertebral deformity and its associations with physical impairment among Japanese women: the Hizen-Oshima Study. Osteoporos Int 13 9 (2002) 723-730
13. Horikawa K., Kasai Y., Yamakawa T., et al. Prevalence of osteoarthritis, osteoporotic vertebral fractures, and spondylolisthesis among the elderly in a Japanese village. J Orthop Surg (Hong Kong) 14 1 (2006) 9-12
14. Burger H., van Daele P.L., Algra D., et al. Vertebral deformities as predictors of non-vertebral fractures. BMJ 309 6960 (1994) 991-992
15. Black D.M., Arden N.K., Palermo L., et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14 5 (1999) 821-828
16. Haentjens P., Autier P., Collins J., et al. Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am 85-A 10 (2003) 1936-1943
17. Ismail A.A., Cockerill W., Cooper C., et al. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int 12 2 (2001) 85-90
18. Johnell O., Oden A., Caulin F., et al. Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int 12 3 (2001) 207-214
19. Kanis J.A., Johnell O., Oden A., et al. The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15 1 (2004) 20-26
20. Melton III L.J., Atkinson E.J., Cooper C., et al. Vertebral fractures predict subsequent fractures. Osteoporos Int 10 3 (1999) 214-221
21. Schousboe J.T., Fink H.A., Lui L.Y., et al. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture. J Bone Miner Res 21 10 (2006) 1557-1564
22. Klotzbuecher C.M., Ross P.D., Landsman P.B., et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15 4 (2000) 721-739
23. Ross P.D., Genant H.K., Davis J.W., et al. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int 3 3 (May 1993) 120-126
24. Ross P.D., Davis J.W., Epstein R.S., et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114 11 (1991) 919-923
25. Nevitt M.C., Ettinger B., Black D.M., et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128 10 (1998) 793-800
26. O'Neill T.W., Cockerill W., Matthis C., et al. Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int 15 9 (2004) 760-765
27. Fink H.A., Ensrud K.E., Nelson D.B., et al. Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT). Osteoporos Int 14 1 (2003) 69-76
28. Cooper C., O'Neill T., and Silman A. The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone 14 Suppl 1 (1993) S89-S97
29. Fink H.A., Milavetz D.L., Palermo L., et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa?. J Bone Miner Res 20 7 (2005) 1216-1222
30. Chappard C., Kolta S., Fechtenbaum J., et al. Clinical evaluation of spine morphometric X-ray absorptiometry. Br J Rheumatol 37 5 (1998) 496-501
31. Ferrar L., and Eastell R. Identification of vertebral deformities in men: comparison of morphometric radiography and morphometric X-ray absorptiometry. Osteoporos Int 10 2 (1999) 167-174
32. Ferrar L., Jiang G., Barrington N.A., et al. Identification of vertebral deformities in women: comparison of radiological assessment and quantitative morphometry using morphometric radiography and morphometric X-ray absorptiometry. J Bone Miner Res 15 3 (2000) 575-585
33. Genant H.K., Li J., Wu C.Y., et al. Vertebral fractures in osteoporosis: a new method for clinical assessment. J Clin Densitom 3 3 (2000) 281-290
34. Greenspan S.L., von Stetten E., Emond S.K., et al. Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J Clin Densitom 4 4 (2001) 373-380
35. Rea J.A., Chen M.B., Li J., et al. Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of analysis precision in normal and osteoporotic subjects. Osteoporos Int 9 6 (1999) 536-544
36. Rea J.A., Li J., Blake G.M., et al. Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int 11 8 (2000) 660-668
37. Rea J.A., Chen M.B., Li J., et al. Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification. J Bone Miner Res 15 3 (2000) 564-574
38. Rea J.A., Chen M.B., Li J., et al. Vertebral morphometry: a comparison of long-term precision of morphometric X-ray absorptiometry and morphometric radiography in normal and osteoporotic subjects. Osteoporos Int 12 2 (2001) 158-166
39. Binkley N., Krueger D., Gangnon R., et al. Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos Int 16 12 (2005) 1513-1518
40. Schousboe J.T., DeBold C.R., Bowles C., et al. Prevalence of vertebral compression fracture deformity by X-ray absorptiometry of lateral thoracic and lumbar spines in a population referred for bone densitometry. J Clin Densitom 5 3 (2002) 239-246
41. Schousboe J.T., and Debold C.R. Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int 17 2 (2006) 281-289
42. Vokes T.J., Dixon L.B., and Favus M.J. Clinical utility of dual-energy vertebral assessment (DVA). Osteoporos Int 14 11 (2003) 871-878
43. Damiano J., Kolta S., Porcher R., et al. Diagnosis of vertebral fractures by vertebral fracture assessment. J Clin Densitom 9 1 (2006) 66-71
44. Vokes T., Bachman D., Baim S., et al. Vertebral fracture assessment: the 2005 ISCD Official Positions. J Clin Densitom 9 1 (2006) 37-46
45. Hartl F., Tyndall A., Kraenzlin M., et al. Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: results of the Basel Osteoporosis Study. J Bone Miner Res 17 2 (2002) 321-330
46. Lunt M., Felsenberg D., Reeve J., et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res 12 11 (1997) 1883-1894
47. Kaptoge S., Armbrecht G., Felsenberg D., et al. When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 19 12 (2004) 1982-1993
48. Yu W., Gluer C.C., Grampp S., et al. Spinal bone mineral assessment in postmenopausal women: a comparison between dual X-ray absorptiometry and quantitative computed tomography. Osteoporos Int 5 6 (1995) 433-439
49. Jergas M., and Genant H.K. Spinal and femoral DXA for the assessment of spinal osteoporosis. Calcif Tissue Int 61 5 (1997) 351-357
50. Dey A., McCloskey E.V., Taube T., et al. Metacarpal morphometry using a semi-automated technique in the assessment of osteoporosis and vertebral fracture risk. Osteoporos Int 11 11 (2000) 953-958
51. Huang C., Ross P.D., Fujiwara S., et al. Determinants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii. Bone 18 5 (1996) 437-442
52. Bauer D.C., Gluer C.C., Genant H.K., et al. Quantitative ultrasound and vertebral fracture in postmenopausal women. Fracture Intervention Trial Research Group. J Bone Miner Res 10 3 (1995) 353-358
53. Frost M.L., Blake G.M., and Fogelman I. Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria. Osteoporos Int 10 6 (1999) 441-449
54. Leidig-Bruckner G., Limberg B., Felsenberg D., et al. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women. Osteoporos Int 11 2 (2000) 102-119
55. Lang T.F., Guglielmi G., van Kuijk C., et al. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30 1 (2002) 247-250
56. Mikhail M.B., Flaster E., and Aloia J.F. Stiffness in discrimination of patients with vertebral fractures. Osteoporos Int 9 1 (1999) 24-28
57. Vogt T.M., Ross P.D., Palermo L., et al. Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group. Mayo Clin Proc 75 9 (2000) 888-896
58. Vokes T.J., Gillen D.L., Pham A.T., et al. Risk factors for prevalent vertebral fractures in black and white female densitometry patients. J Clin Densitom 10 1 (2007) 1-9
59. Kaptoge S., Armbrecht G., Felsenberg D., et al. Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int 17 9 (2006) 1369-1381
60. Quandt S.A., Thompson D.E., Schneider D.L., et al. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc 80 3 (2005) 343-349
61. Kanis J.A., Johnell O., Black D.M., et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone 33 3 (2003) 293-300
62. Kanis J.A., Barton I.P., and Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int 16 5 (2005) 475-482
63. Schousboe J.T., Ensrud K.E., Nyman J.A., et al. Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score>-2.5 for alendronate therapy: a modeling study. J Clin Densitom 9 2 (2006) 133-143
64. Schousboe J.T., Nyman J.A., Kane R.L., et al. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 142 9 (2005) 734-741
65. Olenginski T.P., Newman E.D., Hummel J.L., et al. Development and evaluation of a vertebral fracture assessment program using IVA and its integration with mobile DXA. J Clin Densitom 9 1 (2006) 72-77
66. Brown J.P., and Josse R.G. clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167 10 Suppl (2002) S1-S34
67. ACOG CoP. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Osteoporosis. Number 50, January 2003. Obstet Gynecol 103 1 (2004) 203-216
68. Hodgson S.F., Watts N.B., Bilezikian J.P., et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9 6 (2003) 544-564
69. Foundation NO. Physician guide to prevention and treatment of osteoporosis. Available at:. http://www.nof.org/physguide/index.htm Accessed January 15, 2005
70. Meunier P.J., Delmas P.D., Eastell R., et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther 21 6 (1999) 1025-1044
71. North A.M.S. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause 9 2 (2002) 84-101
72. Siris E.S., Genant H.K., Laster A.J., et al. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int 18 6 (2007) 761-770
73. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 19 (2001) 1434-1441
74. Finkelstein J.S., Hayes A., Hunzelman J.L., et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349 13 (2003) 1216-1226
75. Body J.J., Gaich G.A., Scheele W.H., et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87 10 (2002) 4528-4535
76. Miller P.D., Shergy W.J., Body J.J., et al. Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. J Rheumatol 32 8 (2005) 1556-1562
77. Liu H., Michaud K., Nayak S., et al. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Arch Intern Med 166 11 (2006) 1209-1217
78. Lundkvist J., Johnell O., Cooper C., et al. Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women. Osteoporos Int 17 2 (2006) 201-211
79. Colon-Emeric C.S. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. JAMA 296 24 (2006) 2968-2969
80. Black D.M., Schwartz A.V., Ensrud K.E., et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296 24 (2006) 2927-2938
81. Lindsay R., Silverman S.L., Cooper C., et al. Risk of new vertebral fracture in the year following a fracture. JAMA 285 3 (2001) 320-323
82. Genant H.K., Jergas M., Palermo L., et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11 7 (1996) 984-996
83. Chesnut I.C., Skag A., Christiansen C., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19 8 (2004) 1241-1249
84. Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282 14 (1999) 1344-1352
85. Reginster J., Minne H.W., Sorensen O.H., et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11 1 (2000) 83-91
86. Seeman E., Compston J., Adachi J., et al. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 18 6 (2007) 711-719
87. Cramer J.A., Gold D.T., Silverman S.L., and Lewiecki E.M. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18 8 (2007) 1023-1031
88. Recker R.R., Gallagher R., and MacCosbe P.E. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80 7 (2005) 856-861
89. Siris E.S., Harris S.T., Rosen C.J., et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81 8 (2006) 1013-1022
90. Solomon D.H., Avorn J., Katz J.N., et al. Compliance with osteoporosis medications. Arch Intern Med 165 20 (2005) 2414-2419
91. Huybrechts K.F., Ishak K.J., and Caro J.J. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 38 6 (2006) 922-928
92. Lo J.C., Pressman A.R., Omar M.A., et al. Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int 17 6 (2006) 922-928
93. McCombs J.S., Thiebaud P., McLaughlin-Miley C., et al. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48 3 (2004) 271-287
94. Rossini M., Bianchi G., Di Munno O., et al. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17 6 (2006) 914-921
95. Ettinger M.P., Gallagher R., and MacCosbe P.E. Medication persistence with weekly versus daily doses of orally administered bisphosphonates. Endocr Pract 12 5 (2006) 522-528
96. Caro J.J., Ishak K.J., Huybrechts K.F., et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 15 12 (2004) 1003-1008
97. Pressman A., Forsyth B., Ettinger B., et al. Initiation of osteoporosis treatment after bone mineral density testing. Osteoporos Int 12 5 (2001) 337-342
98. Silverman S.L., Greenwald M., Klein R.A., et al. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol 89 3 (1997) 321-325
99. Pickney C.S., and Arnason J.A. Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int 16 9 (2005) 1156-1160
100. Carr A.J., Thompson P.W., and Cooper C. Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int 17 11 (2006) 1638-1644
101. Ettinger B., Black D.M., Nevitt M.C., et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 7 4 (1992) 449-456
102. Johnell O., O'Neill T., Felsenberg D., et al. Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group. Am J Epidemiol 146 4 (1997) 287-293
103. Nevitt M.C., Cummings S.R., Stone K.L., et al. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res 20 1 (2005) 131-140
104. Jacobs-Kosmin D., Sandorfi N., Murray H., et al. Vertebral deformities identified by vertebral fracture assessment: associations with clinical characteristics and bone mineral density. J Clin Densitom 8 3 (2005) 267-272
105. Eisman J., Clapham S., and Kehoe L. Osteoporosis prevalence and levels of treatment in primary care: the Australian Bone Care Study. J Bone Miner Res 19 12 (2004) 1969-1975
106. Gunnes M., Lehmann E.H., Mellstrom D., et al. The relationship between anthropometric measurements and fractures in women. Bone 19 4 (1996) 407-413
107. Siminoski K., Warshawski R.S., Jen H., et al. The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women. Osteoporos Int 17 2 (2006) 290-296
108. Tobias J.H., Hutchinson A.P., Hunt L.P., et al. Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int 18 1 (2007) 35-43
109. Papaioannou A., Joseph L., Ioannidis G., et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 16 5 (2005) 568-578
110. Krege J.H., Siminoski K., Adachi J.D., et al. A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis. Osteoporos Int 17 3 (2006) 379-386
111. Siminoski K., Jiang G., Adachi J.D., et al. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int 16 4 (2005) 403-410
112. Roux C., Priol G., Fechtenbaum J., et al. A clinical tool to determine the necessity of spine radiography in postmenopausal women with osteoporosis presenting with back pain. Ann Rheum Dis 66 1 (2007) 81-85
113. Gallacher S.J., Gallagher A.P., McQuillian C., et al. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int 18 2 (2007) 185-192
114. Schousboe J.T., Fink H.A., Taylor B.C., et al. Association between self-reported prior wrist fractures and risk of subsequent hip and radiographic vertebral fractures in older women: a prospective study. J Bone Miner Res 20 1 (2005) 100-106
115. Bagger Y.Z., Tanko L.B., Alexandersen P., et al. The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study. Osteoporos Int 17 3 (2006) 471-477
116. Wasnich R.D., Davis J.W., and Ross P.D. Spine fracture risk is predicted by non-spine fractures. Osteoporos Int 4 1 (1994) 1-5
117. van der Klift M., de Laet C.E., McCloskey E.V., et al. Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 19 7 (2004) 1172-1180
118. Delmas P.D., Genant H.K., Crans G.G., et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33 4 (2003) 522-532
119. Van der Klift M., De Laet C.E., McCloskey E.V., et al. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 17 6 (2002) 1051-1056
120. McEvoy C.E., Ensrud K.E., Bender E., et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 3 Pt 1 (1998) 704-709
121. Lespessailles E., Poupon S., Adriambelosoa N., et al. Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?. Joint Bone Spine 67 2 (2000) 119-126
122. Van Staa T.P., Laan R.F., Barton I.P., et al. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48 11 (2003) 3224-3229
123. de Nijs R.N., Jacobs J.W., Bijlsma J.W., et al. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology (Oxford) 40 12 (2001) 1375-1383
124. Naganathan V., Jones G., Nash P., et al. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 160 19 (2000) 2917-2922
125. Lems W.F., Jahangier Z.N., Jacobs J.W., et al. Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol 13 3 (1995) 293-297
126. Peel N.F., Moore D.J., Barrington N.A., et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54 10 (1995) 801-806
127. Tsugeno H., Fujita T., Goto B., et al. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis. Osteoporos Int 13 8 (2002) 650-656
128. Arai K., Hanyu T., Sugitani H., et al. Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab 24 2 (2006) 118-124
129. Bultink I.E., Lems W.F., Kostense P.J., et al. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52 7 (2005) 2044-2050
130. Stockbrugger R.W., Schoon E.J., Bollani S., et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 16 8 (2002) 1519-1527
131. Laan R.F., van Riel P.L., van Erning L.J., et al. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol 31 2 (1992) 91-96
132. van Everdingen A.A., Siewertsz van Reesema D.R., Jacobs J.W., et al. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?. Clin Exp Rheumatol 21 2 (2003) 155-160
133. Walsh L.J., Lewis S.A., Wong C.A., et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 166 5 (2002) 691-695
134. Walsh L.J., Wong C.A., Oborne J., et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 56 4 (2001) 279-284
135. Orstavik R.E., Haugeberg G., Mowinckel P., et al. Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med 164 4 (2004) 420-425
136. Dykman T.R., Gluck O.S., Murphy W.A., et al. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 28 4 (1985) 361-368
137. Michel B.A., Bloch D.A., Wolfe F., et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 20 10 (1993) 1666-1669
138. Sinigaglia L., Nervetti A., Mela Q., et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 27 11 (2000) 2582-2589
139. Giannini S., Nobile M., Dalle Carbonare L., et al. Vertebral morphometry by X-ray absorptiometry before and after liver transplant: a cross-sectional study. Eur J Gastroenterol Hepatol 13 10 (2001) 1201-1207
140. Angeli A., Guglielmi G., Dovio A., et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39 2 (2006) 253-259
141. Klaus J., Armbrecht G., Steinkamp M., et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 51 5 (2002) 654-658
142. Melton III L.J., Patel A., Achenbach S.J., et al. Long-term fracture risk following adult-onset asthma: a population-based study. Osteoporos Int 15 4 (2004) 311-316
143. Melton III L.J., Patel A., Achenbach S.J., et al. Long-term fracture risk among children with asthma: a population-based study. J Bone Miner Res 20 4 (2005>) 564-570
144. De Vries F., Bracke M., Leufkens H.G., et al. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56 1 (2007) 208-214
145. van Staa T.P., Cooper C., Brusse L.S., et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 125 6 (2003) 1591-1597
146. van Staa T.P., Leufkens H.G., Abenhaim L., et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39 12 (2000) 1383-1389
147. Van Staa T.P., Leufkens H.G., Abenhaim L., et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15 6 (2000) 993-1000
148. Orstavik R.E., Haugeberg G., Uhlig T., et al. Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry. Osteoporos Int 16 1 (2005) 35-42
149. Kanis J.A., Johansson H., Oden A., et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19 6 (2004) 893-899
150. Kumagai S., Kawano S., Atsumi T., et al. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. J Rheumatol 32 5 (2005) 863-869
151. Luengo M., Picado C., Del Rio L., et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46 11 (1991) 803-806
152. Hirano Y., Kishimoto H., Hagino H., et al. The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. J Bone Miner Metab 17 2 (1999) 119-124
153. Kaji H., Tobimatsu T., Naito J., et al. Body composition and vertebral fracture risk in female patients treated with glucocorticoid. Osteoporos Int 17 4 (2006) 627-633
154. Evans S.F., and Davie M.W. Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. Ann Rheum Dis 59 4 (2000) 269-275
155. Tsugeno H., Goto B., Fujita T., et al. Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients. Osteoporos Int 12 4 (2001) 266-270
156. Steinbuch M., Youket T.E., and Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15 4 (2004) 323-328
157. Mitra D., Elvins D.M., Speden D.J., et al. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford) 39 1 (2000) 85-89
158. Santavirta S., Konttinen Y.T., Heliovaara M., et al. Determinants of osteoporotic thoracic vertebral fracture. Screening of 57,000 Finnish women and men. Acta Orthop Scand 63 2 (1992) 198-202
159. Vallarta-Ast N., Krueger D., Wrase C., et al. An evaluation of densitometric vertebral fracture assessment in men. Osteoporos Int 18 10 (2007) 1405-1410
160. Lunt M., O'Neill T.W., Felsenberg D., et al. Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS). Bone 33 4 (2003) 505-513
161. Felsenberg D., Silman A., Lunt M., et al. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17 4 (2002) 716-724
162. Greenspan S.L., Coates P., Sereika S.M., et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 90 12 (2005) 6410-6417
163. Daniell H.W., Dunn S.R., Ferguson D.W., et al. Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 163 1 (2000) 181-186
164. Diamond T.H., Higano C.S., Smith M.R., et al. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer 100 5 (2004) 892-899
165. Smith M.R. Treatment-related osteoporosis in men with prostate cancer. Clin Cancer Res 12 20 Pt 2 (2006) 6315s-6319s
166. Lopez A.M., Pena M.A., Hernandez R., et al. Fracture risk in patients with prostate cancer on androgen deprivation therapy. Osteoporos Int 16 6 (2005) 707-711
167. Shahinian V.B., Kuo Y.F., Freeman J.L., et al. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352 2 (2005) 154-164
168. Smith M.R., Lee W.C., Brandman J., et al. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol 23 31 (2005) 7897-7903
169. Smith M.R., Boyce S.P., Moyneur E., et al. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol 175 1 (2006) 136-139 [discussion 139]
170. Melton III L.J., Alothman K.I., Khosla S., et al. Fracture risk following bilateral orchiectomy. J Urol 169 5 (2003) 1747-1750
171. Diamond T.H., Bucci J., Kersley J.H., et al. Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy. J Urol 172 2 (2004) 529-532
172. Makitie O., Doria A.S., Henriques F., et al. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr 146 3 (2005) 395-401
173. Valta H., Lahdenne P., Jalanko H., et al. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol 34 4 (2007) 831-836
174. Helenius I., Remes V., Salminen S., et al. Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study. J Bone Miner Res 21 3 (2006) 380-387
175. Cooper C., Atkinson E.J., O'Fallon W.M., et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7 2 (1992) 221-227
176. Ziegler R., Scheidt-Nave C., and Leidig-Bruckner G. What is a vertebral fracture?. Bone 18 3 Suppl (1996) 169S-177S
177. O'Neill T.W., and Silman A.J. Definition and diagnosis of vertebral fracture. J Rheumatol 24 6 (1997) 1208-1211
178. Hurxthal L.M., Vose G.P., and Dotter W.E. Densitometric and visual observations of spinal radiographs. Geriatrics 24 5 (1969) 93-106
179. Hedlund L.R., and Gallagher J.C. Vertebral morphometry in diagnosis of spinal fractures. Bone Miner 5 1 (1988) 59-67
180. Harma M., Heliovaara M., Aromaa A., et al. Thoracic spine compression fractures in Finland. Clin Orthop 205 (1986) 188-194
181. Ross P.D., Davis J.W., Epstein R.S., et al. Ability of vertebral dimensions from a single radiograph to identify fractures. Calcif Tissue Int 51 2 (1992) 95-99
182. Gallagher J.C., Hedlund L.R., Stoner S., et al. Vertebral morphometry: normative data. Bone Miner 4 2 (1988) 189-196
183. Raymakers J.A., Kapelle J.W., van Beresteijn E.C., et al. Assessment of osteoporotic spine deformity. A new method. Skeletal Radiol 19 2 (1990) 91-97
184. Minne H.W., Leidig G., Wuster C., et al. A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner 3 4 (1988) 335-349
185. McCloskey E.V., Spector T.D., Eyres K.S., et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3 3 (1993) 138-147
186. Black D.M., Cummings S.R., Stone K., et al. A new approach to defining normal vertebral dimensions. J Bone Miner Res 6 8 (1991) 883-892
187. Eastell R., Cedel S.L., Wahner H.W., et al. Classification of vertebral fractures. J Bone Miner Res 6 3 (1991) 207-215
188. Grados F., Roux C., de Vernejoul M.C., et al. Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int 12 9 (2001) 716-722
189. Wu C.Y., Li J., Jergas M., et al. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporos Int 5 5 (1995) 354-370
190. Black D.M., Palermo L., Nevitt M.C., et al. Comparison of methods for defining prevalent vertebral deformities: the study of osteoporotic fractures. J Bone Miner Res 10 6 (1995) 890-902
191. Smith-Bindman R., Cummings S.R., Steiger P., et al. A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res 6 1 (1991) 25-34
192. Ferrar L., Jiang G., Adams J., et al. Identification of vertebral fractures: an update. Osteoporos Int 16 7 (2005) 717-728
193. Genant H.K., and Jergas M. Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporos Int 14 Suppl 3 (2003) S43-S55
194. Genant H.K., Wu C.Y., van Kuijk C., et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8 9 (1993) 1137-1148
195. Antoniou J., Nguyen C., Lander P., et al. Osteoporosis of the spine: correlation between vertebral deformity and bone mineral density in postmenopausal women. Am J Orthop 29 12 (2000) 956-959
196. Vokes T.J., Gillen D.L., Lovett J., et al. Comparison of T-scores from different skeletal sites in differentiating postmenopausal women with and without prevalent vertebral fractures. J Clin Densitom 8 2 (2005) 206-215
197. Abdel-Hamid Osman A., Bassiouni H., Koutri R., et al. Aging of the thoracic spine: distinction between wedging in osteoarthritis and fracture in osteoporosis-a cross-sectional and longitudinal study. Bone 15 4 (1994) 437-442
198. Szulc P., Munoz F., Marchand F., et al. Semiquantitative evaluation of prevalent vertebral deformities in men and their relationship with osteoporosis: the MINOS study. Osteoporos Int 12 4 (2001) 302-310
199. Ito Z., Harada A., Matsui Y., et al. Can you diagnose for vertebral fracture correctly by plain X-ray?. Osteoporos Int 17 11 (2006) 1584-1591
200. Crans G.G., Genant H.K., and Krege J.H. Prognostic utility of a semiquantitative spinal deformity index. Bone 37 2 (2005) 175-179
201. Ferrar L., Jiang G., Eastell R., et al. Visual identification of vertebral fractures in osteoporosis using morphometric X-ray absorptiometry. J Bone Miner Res 18 5 (2003) 933-938
202. Jiang G., Eastell R., Barrington N.A., et al. Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int 15 11 (2004) 887-896
203. Ferrar L., Jiang G., Armbrecht G., et al. Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). Bone 41 1 (2007) 5-12
204. Ferrar L., Jiang G., Cawthon P.M., et al. Identification of vertebral fracture and non-osteoporotic short vertebral height in men: the MrOS study. J Bone Miner Res 22 9 (2007) 1434-1441
205. Ferrar L., Jiang G., Schousboe J.T., et al. Algorithm-based qualitative and seniqualitative indentification of prevalent vertebral fracture: agreement between different traders imaging modalities and diagnostic approaches. J Bone Miner Res (2007) [epub]
206. Pavlov L., Gamble G.D., and Reid I.R. Comparison of dual-energy x-ray absorptiometry and conventional radiography for the detection of vertebral fractures. J Clin Densitom 8 4 (2005) 379-385
207. Ferrar L., Jiang G., and Eastell R. Short-term precision for morphometric X-ray absorptiometry. Osteoporos Int 12 9 (2001) 710-715
208. Rea J.A., Steiger P., Blake G.M., et al. Optimizing data acquisition and analysis of morphometric X-ray absorptiometry. Osteoporos Int 8 2 (1998) 177-183
209. Hasserius R., Redlund-Johnell I., Mellstrom D., et al. Vertebral deformation in urban Swedish men and women: prevalence based on 797 subjects. Acta Orthop Scand 72 3 (2001) 273-278
210. Vallarta-Ast N., Krueger D., and Binkley N. Addition of right lateral decubitus positioning improves vertebral visualization with VFA in selected patients. J Clin Densitom 9 3 (2006) 375-379
211. Chan K.K., Sartoris D.J., Haghighi P., et al. Cupid's bow contour of the vertebral body: evaluation of pathogenesis with bone densitometry and imaging-histopathologic correlation. Radiology 202 1 (1997) 253-256
212. Hilton R.C., Ball J., and Benn R.T. Vertebral end-plate lesions (Schmorl's nodes) in the dorsolumbar spine. Ann Rheum Dis 35 2 (1976) 127-132
213. Lecuyer N., Grados F., Dargent-Molina P., et al. Prevalence of Paget's disease of bone and spinal hemangioma in French women older than 75 years: data from the EPIDOS study. Joint Bone Spine 67 4 (2000) 315-318
214. Harrington K.D. Vertebral compression fractures: differentiation between benign and malignant causes. Iowa Orthop J 13 (1993) 85-96
215. Fornasier V.L., and Czitrom A.A. Collapsed vertebrae: a review of 659 autopsies. Clin Orthop Relat Res 131 (1978) 261-265
216. Wong D.A., Fornasier V.L., and MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine 15 1 (1990) 1-4
217. Haller J., Andre M.P., Resnick D., et al. Detection of thoracolumbar vertebral body destruction with lateral spine radiography. Part II: clinical investigation with computed tomography. Invest Radiol 25 5 (1990) 523-532
218. Schneider D.L., Bettencourt R., and Barrett-Connor E. Clinical utility of spine bone density in elderly women. J Clin Densitom 9 3 (2006) 255-260
219. Wilson P.W., Kauppila L.I., O'Donnell C.J., et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103 11 (2001) 1529-1534
220. van der Meer I.M., Bots M.L., Hofman A., et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 109 9 (2004) 1089-1094
221. Schousboe JT, Taylor BC, Kiel DP, et al. 2007 Abdominal aortic calcification (AAC) on vertebral fracture assessment images predicts incident myocardial infarction or stroke independent of clinical cardiovascular disease risk factors. J Bone Miner Res [e pub].
222. Hollander M., Hak A.E., Koudstaal P.J., et al. Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 34 10 (2003) 2367-2372
223. Walsh C.R., Cupples L.A., Levy D., et al. Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study. Am Heart J 144 4 (2002) 733-739
224. Schousboe J.T., Wilson K.E., and Hangartner T.N. Detection of aortic calcification during vertebral fracture assessment (VFA) compared to digital radiography. PLoS ONE 2 1 (2007) e715
225. Ginsberg M.D. Beyond the viewbox: the radiologist's duty to communicate findings. John Marshall Law Rev 35 (2002) 359-380
226. Berlin L. Defending the "missed" radiographic diagnosis. AJR Am J Roentgenol 176 2 (2001) 317-322
227. Wu C., van Kuijk C., Li J., et al. Comparison of digitized images with original radiography for semiquantitative assessment of osteoporotic fractures. Osteoporos Int 11 1 (2000) 25-30
228. Sauer P., Leidig G., Minne H.W., et al. Spine deformity index (SDI) versus other objective procedures of vertebral fracture identification in patients with osteoporosis: a comparative study. J Bone Miner Res 6 3 (1991) 227-238
229. Herss Nielsen V.A., Podenphant J., Martens S., et al. Precision in assessment of osteoporosis from spine radiographs. Eur J Radiol 13 1 (1991) 11-14